We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CSAMF market cap is 100.75M. The company's latest EPS is NOK -6.2931 and P/E is -0.77.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Revenue | 168.93M | 207.23M | 229.81M | 330.66M | 369.66M |
| Operating Income | 16.39M | -9.11M | 17.26M | -39.54M | -90.45M |
| Net Income | -3.64M | -29.45M | -9.23M | -89.12M | -131.6M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Assets | 266.98M | 326.53M | 661.41M | 815.13M | 693.54M |
| Total Liabilities | 257.66M | 352.8M | 413.06M | 648.53M | 664.77M |
| Total Equity | 9.33M | -26.27M | 248.35M | 166.6M | 28.77M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Operating | 20.72M | 63.71M | 28.95M | 21.98M | 11.64M |
| Investing | -56.68M | -102.63M | -27.54M | -226.09M | -61.98M |
| Financing | 37.06M | 43.47M | 280.53M | 180.35M | -34.61M |
| Market Cap | 100.75M |
| Price to Earnings Ratio | -0.77 |
| Price to Sales Ratio | 0.27 |
| Price to Cash Ratio | 0.51 |
| Price to Book Ratio | 3.5 |
| Dividend Yield | - |
| Shares Outstanding | 20.91M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Csam Health Group AS (CE) |
| Address |
drammensveien 288 oslo 0283 |
| Website | https://www.omda.com |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
